Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Combination of Toripalimab and Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

NCT04005170 is registered in ClinicalTrials.gov with Mian XI as lead sponsor.

NCT NCT04005170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Combination of Toripalimab and Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Lead sponsor
Mian XI
Phase
Phase 2
Overall status
Completed
Start date
June 25, 2019
Completion date
July 31, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable esophageal cancer